Mary-Jeanet McGarry

FDA investigator

Appears on 3 documents from 2016 to 2026, most often at sites in Connecticut. Most often cites design and construction features (21 CFR 211.42).

3
Documents on file
8.7
Observations per 483
2016
First seen
2026
Most recent

What they cite most

From 26 observations

Activity by year

2016: 1, 2023: 1, 2026: 1

Where

Connecticut 1 · Minnesota 1 · South Carolina 1

Is Mary-Jeanet McGarry coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
483 IntegraDose Compound ing Services LLCAug 12, 2026 · Shoreview, Minnesota
483 Nephron Sterile Compounding Center LLCFeb 10, 2023 · West Columbia, South Carolina
483 Central Admixture Pharmacy Services Inc.Jan 29, 2016 · Wallingford, Connecticut

About this profile

What does Mary-Jeanet McGarry inspect?

Mary-Jeanet McGarry appears on 3 documents on file covering 3 sites, most often in Connecticut.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Mary-Jeanet McGarry is dated Aug 12, 2026.